Lipid analogues as potential drugs for the regulation of mitochondrial cell death

British Journal of Pharmacology

Volumn 171, Issue 8, 2014, Pages 2051-2066

  Murray, Michael ^a   Dyari, Herryawan Ryadi Eziwar ^a   Allison, Sarah E ^a   Rawling, Tristan ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

cancer cell; ether phospholipids; fatty acid biotransformation; free fatty acids; intrinsic pathway of apoptosis; mitochondrial ATP production; N acylethanolamines; polyunsaturated fatty acid epoxides; reactive oxygen species

Indexed keywords

13 METHYLMYRISTIC ACID; 4 [4 [3 (1 ADAMANTYL)UREIDO]CYCLOHEXYLOXY]BENZOIC ACID; ADENOSINE TRIPHOSPHATE; ANANDAMIDE; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; BUTYRIC ACID; CARDIOLIPIN; CERAMIDE; CICAPROST; CONJUGATED LINOLEIC ACID; DOCOSAHEXAENOIC ACID; EDELFOSINE; EPOXYICOSATRIENOIC ACID; ETOPOSIDE; HYDROXYICOSATETRAENOIC ACID; ICOSAPENTAENOIC ACID; ILMOFOSINE; JASMONIC ACID; LIPID; MILTEFOSINE; PALMITIC ACID; PERIFOSINE; PROPIONIC ACID; PROSTAGLANDIN E2; SATURATED FATTY ACID; SORAFENIB; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNSATURATED FATTY ACID; VACCENIC ACID; FATTY ACID; PHOSPHOLIPID;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG STRUCTURE; ENDOMETRIUM CANCER; ENERGY METABOLISM; GLYCOLYSIS; HODGKIN DISEASE; HUMAN; INTRACELLULAR SIGNALING; LEWIS CARCINOMA; LIPOGENESIS; LIVER CELL CARCINOMA; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; MULTIPLE MYELOMA; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; REVIEW; BIOSYNTHESIS; DRUG EFFECTS; LIPID METABOLISM; METABOLISM; NEOPLASMS; PHYSIOLOGY; PROCEDURES;

ADENOSINE TRIPHOSPHATE; ANTICARCINOGENIC AGENTS; CELL DEATH; ENERGY METABOLISM; FATTY ACIDS; LIPID METABOLISM; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHOSPHOLIPIDS;

EID: 84897406015     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12417     Document Type: Review

References (143)

1. Ackerstaff E, Glunde K, Bhujwalla ZM, (2003). Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 90: 525-533.
2. Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, Matsuzaki M, et al. (2002). Direct activation of mitochondrial apoptosis machinery by c- Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277: 10244-10250.
3. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, et al. (2001). Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15: 2007-2009.
4. Bernardi P, Penzo D, Wojtczak L, (2002). Mitochondrial energy dissipation by fatty acids. Vitam Horm 65: 97-126.
5. Bremer J, Bjerve KS, Borrebaek B, Christiansen R, (1976). The glycerophosphate acyltransferases and their function in the metabolism of fatty acids. Mol Cell Biochem 12: 113-125.
6. Brenner C, Cardiou H, Vieira HL, Zamzami N, Marzo I, Xie Z, et al. (2000). Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19: 329-336.
7. Brimmell M, Mendiola R, Mangion J, Packham G, (1998). BAX frameshift mutations in cell lines derived from human hematopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16: 1803-1812.
8. Broekemeier KM, Pfeiffer DR, (1995). Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry 34: 16440-16449.
9. Burgeiro A, Pereira CV, Carvalho FS, Pereira GC, Mollinedo F, Oliveira PJ, (2013). Edelfosine and perifosine disrupt hepatic mitochondrial oxidative phosphorylation and induce the permeability transition. Mitochondrion 13: 25-35.
10. Cabaner C, Gajate C, Macho A, Munoz E, Modolell M, Mollinedo F, (1999). Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system. Br J Pharmacol 127: 813-825.
11. Cadenas E, Davies KJ, (2000). Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29: 222-230.
12. Cao M, Prima V, Nelson D, Svetlov S, (2013). Composite fatty acid ether amides suppress growth of liver cancer cells in vitro and in an in vivo allograft mouse model. Cell Oncol 36: 247-257.
13. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM, (2000). Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 97: 11280-11285.
14. Chen C, Li G, Liao W, Wu J, Liu L, Ma D, et al. (2009). Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo. J Pharmacol Exp Ther 329: 908-918.
15. Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, Lin YS, (2008). Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 111: 4365-4374.
16. Chen J, Murray M, Liddle C, Jiang XM, Farrell GC, (1995). Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis. Hepatology 22: 580-587.
17. Chiarini F, Del Sole M, Mongiorgi S, Gaboardi GC, Cappellini A, Mantovani I, et al. (2008). The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 22: 1106-1116.
18. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, Lee HS, et al. (2003). Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 284: G996-1005.
19. Collins PW, Djuric SW, (1993). Synthesis of therapeutically useful prostaglandin and prostacyclin analogs. Chem Rev 93: 1533-1564.
20. Colquhoun A, (2009). Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction. J Urol 181: 1885-1893.
21. Cui PH, Petrovic N, Murray M, (2011). The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 downregulation. Br J Pharmacol 162: 1143-1155.
22. Cui PH, Rawling T, Bourget K, Kim T, Duke CC, Doddareddy MR, et al. (2012). Antiproliferative and antimigratory actions of synthetic long chain n-3 monounsaturated fatty acids in breast cancer cells that overexpress cyclooxygenase-2. J Med Chem 55: 7163-7172.
23. Das S, Chandrasekhar S, Yadav JS, Gree R, (2007). Recent developments in the synthesis of prostaglandins and analogues. Chem Rev 107: 3286-3337.
24. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, et al. (1998). The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 95: 8375-8380.
25. De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV, (2003). RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res 63: 3799-3804.
26. Denys A, Hichami A, Khan NA, (2005). n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J Lipid Res 46: 752-758.
27. Di Paola MD, Lorusso M, (2006). Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition. Biochem Biophys Acta 1757: 1330-1337.
28. Duffy CD, Guiry PJ, (2010). Recent advances in the chemistry and biology of stable synthetic Lipoxin analogues. MedChemComm 1: 249-265.
29. 2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissue. J Biol Chem 257: 1383-1391.
30. Fillet M, Bentires-Alj M, Deregowski V, Greimers R, Gielen J, Piette J, et al. (2003). Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochem Pharmacol 65: 1633-1642.
31. Fingrut O, Flescher E, (2002). Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 16: 608-616.
32. Fingrut O, Reischer D, Rotem R, Goldin N, Altboum I, Zan-Bar I, et al. (2005). Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Br J Pharmacol 146: 800-808.
33. Flowers M, Fabrias G, Delgado A, Casas J, Abad JL, Cabot MC, (2012). C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth. Breast Cancer Res Treat 133: 447-458.
34. Fulda S, Debatin KM, (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811.
35. Gajate C, Santos-Beneit M, Macho A, del Carmen Lazaro M, Hernandez- De Rojas A, Modolell M, et al. (2000). Involvement of mitochondria and caspase-3 in Et-18-OCH3-induced apoptosis of human leukemic cells. Int J Cancer 86: 208-218.
36. Galiegue S, Jbilo O, Combes T, Bribes E, Carayon P, Le Fur G, et al. (1999). Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepin receptor. J Biol Chem 274: 2938-2952.
37. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC, (1997). Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 272: 11369-11377.
38. Gasmi J, Sanderson JT, (2010). Growth inhibitory, antiandrogenic, and pro-apoptotic effects of punicic acid in LNCaP human prostate cancer cells. J Agric Food Chem 58: 12149-12156.
39. Gasmi J, Sanderson JT, (2013). Jacaric acid and its octadecatrienoic acid geoisomers induce apoptosis selectively in cancerous human prostate cells: a mechanistic and 3-D structure-activity study. Phytomedicine 20: 734-742.
40. Ghosh J, Myers CE, (1998). Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95: 13182-13187.
41. Goldin N, Heyfets A, Reischer D, Flescher E, (2007). Mitochondria- mediated ATP depletion by anti-cancer agents of the jasmonate family. J Bioenerg Biomemb 39: 51-57.
42. Goldin N, Arzoine L, Heyfets A, Israelson A, Zaslavsky Z, Bravman T, et al. (2008). Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 27: 4636-4643.
43. Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, et al. (1997). Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27: 284-292.
44. Grossmann ME, Mizuno NK, Dammen ML, Schuster T, Ray A, Cleary MP, (2009). Eleostearic acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism. Cancer Prev Res 2: 879-886.
45. Grossmann ME, Mizuno NK, Schuster T, Cleary MP, (2010). Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. Int J Oncol 36: 421-426.
46. Gudz TI, Tserng KY, Hoppel CL, (1997). Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem 272: 24154-24158.
47. Gulaya NM, Melnik AA, Balkov DI, Volkov GL, Vysotskiy MV, Vaskovsky VE, (1993). The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastoma C1300 N18 cells. Biochim Biophys Acta 1152: 280-288.
48. Gulaya NM, Kuzmenko AI, Margitich VM, Govseeva NM, Melnichuk SD, Goridko TM, et al. (1998). Long-chain N-acylethanolamines inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia. Chem Phys Lipids 97: 49-54.
49. Gutknecht J, (1988). Proton conductance caused by long-chain fatty acids in phospholipid bilayer membranes. J Membrane Biol 106: 83-93.
50. Hague A, Diaz GD, Hicks DJ, Krajewski S, Reed JC, Paraskeva C, (1997). Bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis. Int J Cancer 72: 898-905.
51. Hanahan D, Weinberg RA, (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
52. Heerdt BG, Houston MA, Augenlicht LH, (1997). Short-chain fatty acid initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 8: 523-532.
53. Heerdt BG, Houston MA, Anthony GM, Augenlicht LH, (1998). Mitochondrial membrane potential (ΔΨ) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res 58: 2869-2875.
54. Heyfets A, Flescher E, (2007). Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose. Cancer Lett 50: 300-310.
55. Hideshima T, Catley L, Yasui H, Ishitsuka K, Raje N, Mitsiades C, et al. (2006). Perifosine, an oral bioactive novel alkylphospholipid, inhibits akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood 107: 4053-4062.
56. Higdon A, Diers AR, Oh JY, Landar A, Darley-Usmar VM, (2012). Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem J 442: 453-464.
57. 3H-cicaprost in healthy volunteers. Prostaglandins 37: 259-273.
58. Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, et al. (2005). Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 26: 785-791.
59. Hostetler KY, van den Bosch H, (1972). Subcellular and submitochondrial localization of the biosynthesis of cardiolipin and related phospholipids in rat liver. Biochim Biophys Acta 260: 380-386.
60. Hvattum E, Bergseth S, Pedersen CN, Bremer J, Aarsland A, Berge RK, (1991). Microsomal oxidation of dodecylthioacetic acid (a 3-thia fatty acid) in rat liver. Biochem Pharmacol 41: 945-953.
61. Ip C, Ip MM, Loftus T, Shoemaker S, Shea-Eaton W, (2000). Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidemiol Biomarkers Prev 9: 689-696.
62. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, Ip C, (1999). Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250: 22-34.
63. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, et al. (2006). Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446-451.
64. Iversen PO, Sørensen DR, Tronstad KJ, Gudbrandsen OA, Rustan AC, Berge RK, et al. (2006). A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia. Clin Cancer Res 12: 3525-3531.
65. Jensen LR, Berge K, Bathen TF, Wergedahl H, Schonberg SA, Bofin A, et al. (2007). Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI. Cancer Biol Ther 6: 1810-1816.
66. Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 65: 4707-4715.
67. Kamp F, Hamilton JA, (1992). pH gradients across phospholipid membranes caused by fast flip-flop of unionized fatty acids. Proc Natl Acad Sci USA 89: 11367-11370.
68. Kanazawa A, Tanaka A, Iwata S, Satoh S, Hatano E, Shinohara H, et al. (1998). The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death. J Surg Res 80: 229-235.
69. Kharbanda S, Saxena S, Yoshida K, Pandey P, Kaneki M, Wang Q, et al. (2000). Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem 275: 322-327.
70. Kim EJ, Holthuizen PE, Park HS, Ha YL, Jung KC, Park JH, (2002). Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth. Am J Physiol Gastrointest Liver Physiol 283: G357-G367.
71. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD, (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
72. Koehne CH, Dubois RN, (2004). COX-2 inhibition and colorectal cancer. Semin Oncol 31 (2 Suppl 7): 12-21.
73. Kondapaka SB, Singh SS, Dasmahapatra GP, Sausville EA, Roy KK, (2003). Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther 2: 1093-1103.
74. 2 by mitochondria in the resting state. FEBS Lett 435: 215-218.
75. Kroemer G, Galluzzi L, Brenner C, (2007). Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163.
76. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, et al. (2002). Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342.
77. Larsen NB, Rasmussen M, Rasmussen LJ, (2005). Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion 5: 89-108.
78. Lin T, Yin X, Cai Q, Fan X, Xu K, Huang L, et al. (2012). 13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cells. Urolog Oncol 30: 339-345.
79. Locatelli SL, Giacomini A, Guidetti A, Cleris L, Mortarini R, Anichini A, et al. (2013). Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts. Leukemia 27: 1677-1687.
80. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A, (2000). Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 275: 31938-31945.
81. Maccarrone M, Melino G, Finazzi-Agro A, (2001). Lipoxygenases and their involvement in programmed cell death. Cell Death Diff 8: 776-784.
82. Machida K, Ohta Y, Osada H, (2006). Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells. J Biol Chem 281: 14314-14320.
83. McLaughlin SGA, Dilger JP, (1980). Transport of protons across membranes by weak acids. Physiol Rev 60: 825-863.
84. Marden NY, Fiala-Beer E, Xiang SH, Murray M, (2003). Role of activator protein-1 in the downregulation of the human CYP2J2 gene in hypoxia. Biochem J 373: 669-680.
85. Mari M, Morales A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC, (2009). Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11: 2685-2700.
86. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, et al. (1998a). The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 187: 1261-1271.
87. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, et al. (1998b). Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027-2031.
88. Merad-Boudia M, Nicole A, Santiard-Baron D, Saillé C, Ceballos-Picot I, (1998). Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem Pharmacol 56: 645-655.
89. Merrill AH Jr, Jones DD, (1990). An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta 1044: 1-12.
90. Miccoli L, Beurdeley-Thomas A, De Pinieux G, Sureau F, Oudard S, Dutrillaux B, et al. (1998). Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 58: 5777-5786.
91. Miller A, McGrath E, Stanton C, Devery R, (2003). Vaccenic acid (t11-18:1) is converted to c9,t11-CLA in MCF-7 and SW480 cancer cells. Lipids 38: 623-632.
92. Milovic V, Teller IC, Turchanowa L, Caspary WF, Stein J, (2000). Effect of structural analogues of propionate and butyrate on colon cancer cell growth. Int J Colorectal Dis 15: 264-270.
93. Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, et al. (1997). Selective induction of apoptosis in cancer cells by the ether lipid ET- 18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res 57: 1320-1328.
94. Mollinedo F, Fernandez M, Hornillos V, Delgado J, Amat-Guerri F, Acuna AU, et al. (2011). Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis 2: e158.
95. Murray M, (1999). Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes. Int J Mol Med 3: 227-238.
96. Nathan C, Cunningham-Bussel A, (2013). Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol 13: 349-361.
97. Nieto-Miguel T, Gajate C, Mollinedo F, (2006). Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells. J Biol Chem 281: 14833-14840.
98. Nyåkern M, Cappellini A, Mantovani I, Martelli AM, (2006). Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol Cancer Ther 5: 1559-1570.
99. 2 formation. N Engl J Med 319: 689-698.
100. Oliw EH, (1994). Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog Lipid Res 33: 329-354.
101. Ookhtens M, Kannan R, Lyon I, Baker N, (1984). Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol 247: R146-R153.
102. Ostrander DB, Sparagna GC, Amoscato AA, McMillin JB, Dowhan W, (2001). Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem 276: 38061-38067.
103. de Pablo MA, Susin SA, Jacotot E, Larochette N, Costantini P, Ravagnan L, et al. (1999). Palmitate induces apoptosis via a direct effect on mitochondria. Apoptosis 4: 81-87.
104. Petrosillo G, Ruggiero FM, Paradies G, (2003). Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 17: 2202-2208.
105. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M, (2011). Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochem Biophys Acta 1807: 726-734.
106. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF, (1998). Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58: 4611-4615.
107. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, et al. (2000). Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766.
108. Ramirez M, Amate L, Gil A, (2001). Absorption and distribution of dietary fatty acids from different sources. Early Hum Dev 65: S95-S101.
109. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA, (2004). Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985-993.
110. Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E, (2005). Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res 65: 1984-1993.
111. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG, (1999). Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic bak and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Diff 6: 729-735.
112. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M, (1999). Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res 59: 2457-2463.
113. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M, (2003). Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs 14: 167-173.
114. Sabine JR, Abraham S, Chaikoff IL, (1967). Control of lipid metabolism in hepatomas: insensitivity of rate of fatty acid and cholesterol synthesis by mouse hepatoma BW7756 to fasting and to feedback control. Cancer Res 27: 793-799.
115. Samudio I, Fiegl M, Andreeff M, (2009). Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69: 2163-2166.
116. Sarker KP, Obara S, Nakata M, Kitajima I, Maruyama I, (2000). Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett 472: 39-44.
117. Schlame M, Rua D, Greenberg ML, (2000). The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39: 257-288.
118. Schmid PC, Wold LE, Krebsbach RJ, Berdyshev EV, Schmid HH, (2002). Anandamide and other N-acylethanolamines in human tumours. Lipids 37: 907-912.
119. Schwarz H, Blanco FJ, Lotz M, (1994). Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 55: 107-115.
120. Shimizu S, Narita M, Tsujimoto Y, (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487.
121. Shinohara N, Tsuduki T, Ito J, Honma T, Kijima R, Sugawara S, et al. (2012). Jacaric acid, a linolenic acid isomer with a conjugated triene system, has a strong antitumor effect in vitro and in vivo. Biochim Biophys Acta 1821: 980-988.
122. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, et al. (1997). Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J 16: 6151-6161.
123. Skulachev VP, (1998). Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1363: 100-124.
124. Spector AA, Yorek MA, (1985). Membrane lipid composition and cellular function. J Lipid Res 26: 1015-1035.
125. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446.
126. Szymczak M, Murray M, Petrovic N, (2008). Modulation of angiogenesis by ω-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 111: 3514-3521.
127. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al. (2006). Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10: 241-252.
128. Tronstad KJ, Berge K, Dyroy E, Madsen L, Berge RK, (2001). Growth reduction in glioma cells after treatment with tetradecylthioacetic acid: changes in fatty acid metabolism and oxidative status. Biochem Pharmacol 61: 639-649.
129. Tronstad KJ, Gjertsen BT, Krakstad C, Berge K, Brustugun OT, Doskeland SO, et al. (2003). Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells. Chem Biol 10: 609-618.
130. Tsujii M, Kawano S, DuBois RN, (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340.
131. Tsuzuki T, Tokuyama Y, Igarashi M, Miyazawa T, (2004). Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 25: 1417-1425.
132. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD, (2002). Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45: 2615-2623.
133. Venturini I, Zeneroli ML, Corsi L, Avallone R, Farina F, Alho H, et al. (1998). Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci 63: 1269-1280.
134. Vrablic AS, Albright CD, Craciunescu CN, Salganic RI, Zeisel SH, (2001). Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine in p53-defective hepatocytes. FASEB J 15: 1739-1744.
135. Wasilewski M, Wieckowski MR, Dymkowska D, Wojtczak L, (2004). Effects of N-acylethanolamines on mitochondrial energetics and permeability transition. Biochim Biophys Acta 1657: 151-163.
136. Wieckowski MR, Wojtczak L, (1998). Fatty acid-induced uncoupling of oxidative phosphorylation is partly due to opening of the mitochondrial permeability transition pore. FEBS Lett 423: 339-342.
137. Wongtangtintharn S, Oku H, Iwasaki H, Inafuku M, Toda T, Yanagita T, (2005). Incorporation of branched-chain fatty acid into cellular lipids and caspase-independent apoptosis in human breast cancer cell line, SKBR-3. Lipids Health Dis 4: 29.
138. Woodfield K, Ruck A, Brdiczka D, Halestrap AP, (1998). Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336: 287-290.
139. Yang QH, Church-Hajduk R, Ren J, Newton ML, Du C, (2003). Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 17: 1487-1496.
140. Yang Z, Liu S, Chen X, Chen H, Huang M, Zheng J, (2000). Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-methyltetradecanoic acid. Cancer Res 60: 505-509.
141. Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J, et al. (2011). Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev 25: 1041-1051.
142. Zborowski J, Wojtczak L, (1969). Phospholipid synthesis in rat-liver mitochondria. Biochim Biophys Acta 187: 73-84.
143. Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, et al. (2013). Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA 110: 6530-6535.